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Human Herpesvirus Type 8 DNA Sequences in Cell-Free Plasma and
Mononuclear Cells of Kaposi's Sarcoma Patients
WiDiam J. Barrington, Jr., Omar Bagora, Carlos E. Sosa,
Usa E. Bobrosld, Marianna Baum, XueLan Wen,
Usa Cabral, Gerald E. Byrne, RogerJ. Pomerantz,
and CharlesWood

Department of Mldichle, DMstona of Hematology/Oncology and
MicroblologylImmunology, Department of Nsurology, Untwratty of
Miami School of Medicine, and Cedan Mldical Center, Miam~ Florida,'
Dorrance H. Hamilton Laboratories, Center for Human Virology,
DMston ofInfectiO/l8 Dtseases, Department ofMedicine, Thomas
Jefferson UnIversity, Phlladelphla, Pemt8)lIvania

Human herpesvirus (HHV) type 8 bas been detectedin both classical and AIDS-related Kaposi's
slU'C01Dll, body-cavity lymphomas, and other types of tumors. HHV-8 bas also been detected in
DNA from peripheral blood mononuclear cells (PBMC) of some Kaposi's sarcoma patients and
more readily in Bcellfractions derivedfrom pllllDed cellsubpopu1at1ons. TwopatientswerefoUowed
using several methods: in situhybridization, solutton-based polymerase chain reaction (PeR), and
in situ PCR. HHV-8 was Intermittently detectedIn Plasma.and detectioncorrelated with detection
In PBMC. In situ PCR demonstrated HHV-8 sequences in both peripheral blood B lymphocytes
and, to a lesser extent,T lymphocytes. HHV-8 mayundergo periodsof viremia whileat other times
It Is undetectable and Infects clrculatlng B cells and someT celli.

Nucleic acid sequences of Kaposi's sarcoma (KS)-associ&ted herpesvirus or human herpesvirus (HHV) type 8 have
been detected in both classical andAIDS-related forms of KS,
lymphoma, Castleman's disease, and skin cancers from organ
allogra:ft recipients [1-4]. These sequences were alsofound in
DNA extracted from the peripheral blood mononuclear cells
(PBMC) ofsome KS patients [5,6]. Detection ofHHV-8 sequences in PBMC of human immunodeficiency virus (HIV)
type I-seropositive persons also comlates with an inc.teased
risk of development of KS [5]. Preliminary evidence suggests
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that the target cells in PBMC could be B lymphocytes [6].
HHV-8wasalsodetected in episomal fonninB celllymphoma
cell lines by in situ hybridization [7], and more recently, in
microvascular endothelial cells (MVEC) and spindle cells from
KS lesions by in situpolymerase chain reaction (IS-PCR) [8].
We describe 2 patients, followed longitudinally, in whom
HHV-8 was detected in tumor tissues, T and B lymphocyte
fractions, and cell-free plasma.

Materials and Methods
Patients. Twopatients,1 with AIDS-associated KS and 1 with
posttransplant KS, were followed longitudinally.
Patient A was a 34-year-old man with AIDS (CDC stage IV)
who presented with visceromegaly, diffuse adenopathy, and an
elevated lactate dehydrogenase of 1100 U/dL. A lymph node biopsy revealed KS mixed with areas consistent with angioimmunoblastic lymphadenopathy. The patient was treatedwith intravenous foscarnet for 2 weeks, resulting in gradual diminution of his
tumor and normalization of his lactate dehydrogenase level [9].
After discontinuation of foscamet, his tumor slowly reappeared..
The patient's sen:un was tested for the presence of Epstein-Barr
virus (BBV) antibody and was negative. In addition, the PBMC
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were also tested for EBV gene sequences by PCR (HCLF-i, immediate-early gene) and shown to be negative (not shown).
Patient B was a 49-year-old Hlv-Iv-scronegative man who had
had a renal transplant 7 years earlier for end-stage renal disease.
He was taking immunosuppressive drugs (cyclosporine, azathioprine, and prednisone) and, 3 years after transplant, developed
lower-extremity cutaneous lesions, which proved to be KS on
biopsy. Reduction in the immunosuppressive therapy resulted in
slight improvement of his tumor. The patient's PBMC were negative by PCR for EBV gene sequences.
Solution-based PCR. DNA was extracted from PBMC (1-2
X 106) , and tissue biopsies and PCR were done. DNA (500 ng)
was amplified by HHV-8-specific primers (5'-AGCCGAAAGGATTCCACCATT-3' and Y-TCCGTGTTGTCTACGTCCAGA3'), using published conditions [10] and analyzed on 1% agarose/
ethidium-bromide gels. The predicted size ofthe specific amplified
band was 233 bp (nt 987 - 1219 of the published HHV-8 sequence)
[10]. To prepare a cell-free virus pellet, plasma was centrifuged
at 1800 rpm for 15 min to remove cells and further centrifuged at
3500 rpm for 20 min to remove debris. To pellet virus particles,
5 mL of cell-free plasma was centrifuged at 20,000 rpm using a
SW41 Beckman rotor at 4°C for 2 h [11], and pelleted material
was resuspended in PBS. The pellets were treated with DNase at
37°C for 30 min (another aliquot was untreated) to rule out possible
contamination by infected cellular DNA. This treatment was effective, as it removed any exogenous viral plasmid DNA spiked into
a control serum. DNA from the pelleted viruses was then extracted
by phenol, followed by ethanol precipitation.
In situ PCR and hybridization.
isolated PBMC or subsets (T and B lymphocytes) from both patients were transferred
to salinated slides containing a 20-111111 single well. The cells were
air-dried overnight, dipped in absolute methanol for 5 min, and
then washed twice in IX PBS (Ca~+- and Mg-T-free). Appropriate
concentrations of fluorescein isothiocyanate -conjugated monoclonal antibodies directed against T and B cell epitopes, antiCD3 and anti-CD I 9, respectively, were applied separately to each
individual slide. After a I-h incubation at 37°C, the slides were
heat-fixed at 105°C for lOs and then incubated in 4% paraforrnaldehyde for 2 h. Paraformaldehyde was inactivated by incubating
slides in 3x PBS for 10 min; the slides were then washed twice
in I X PBS, for 10 min per wash. These slides were incubated
overnight in 0.03% freshly prepared hydrogen peroxide in 1X
PBS, to quench the endogenous peroxidase activity. These slides
were treated with proteinase K (6 ,ug/mL) at room temperature for
12 min. Proteinase K was inactivated
incubating slides on a
heat block at 95°C for 5 min. The HHV-8 DNA was amplified in
situ with primers that anneal to nt 987-1006 and 1200- 1219 [10].
Amplified DNA signals were detected
a biotinylated probe,
which anneals at nt 1078- I 102 within the amplicons. In situ hybridization was done at 37°C, using a reaction mixture containing
20 pmol of probe, 50% deionized formamide, 2x SSC (1 X standard saline citrate = 0.15 MNaCI, 0.015 M sodium citrate), lOX
Denhardt's solution, I mg/mL ssDNA, and 0.1% SDS. Amplified
DNA was detected using strepavidin-peroxidase; subsequent color
was developed using 3-amino 9-ethylcarbazole, and counterstaining was done with Gill's hematoxylin [12, 13]. The percentage
of HHV-8-positive cells was determined by counting at least
10,000 cells/slide by 2 independent observers. All microscopic
analyses were done on coded slides.
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Table 1. Detection ofHHV-8 sequences by polymerase chain reaction (PCR) in patient cells and cell-free plasma.

Time points

Cell-free
plasma
pellet

Date

PBMC

4-17-95
4-24-95
5-2-95
5-11-95
8-8-95
8-29-95
9-19-95

+
+/-

+

+

+

+

+

7-14-95
7-26-95
8-16-95
9-17-95

+

+

T cells

13 cells

Kaposi's sarcoma
patient A
1
2

3
4
5
6
7

+
+

Kaposi's sarcoma
patient B
1
2

3
4

NOTE. Cell-free plasma was ultracentrifuged, and pelleted material was
tested forpresence ofHHV-8sequences. PCR was done at selected time points.
when material was available. PBMC, peripheral blood mononuclear cells.

PBMC were separated with immunomagnetic beads coated with
high-affinity monoclonal antibodies (Immunotech, Westbrook,
MA) into T and B lymphocyte fractions, using the manufacturer's
suggested protocol. Fluorescence-activated cell sorting analysis of
the Band T cell fractions demonstrated 95% purity by CD 19
and CD3 positivity, respectively. PBMC of patient B were also
separated by this technique into Band T cell fractions and found
to be 99.5% pure B or T cells. For positive internal controls, the
conserved region ofHLA-DQAI, using primers HLA-DQ-GH2627 (Synthetic Genetics, San Diego), was amplified (not shown).
Negative controls for each assay were PBMC from HHV-8-ncgative, HIV-L-seronegative persons. Positive controls contained a
mixture of an HHV-8- infected MVEC developed in our laboratory
(data not shown) mixed with an HHV-8-negative MVEC cell
line containing 10% HHV-8-positive cells. Additional negative
controls involved the use of irrelevant primers and unrelated probes
(e.g., EBV- and cytomegalovirus-specific), as previously reported
[11,12].

Results
Fluctuation in HHV-8 viremia determined by PCR analyses.
Seven blood samples were taken from patient A over 3 months,
and 4 were taken from patient B over 2 months (table I). PCR
was done on both patients' original tumor biopsies, PBMC, and
pelleted plasma (table I). Both tumor biopsies were positive by
PCR. PBMC from patient A were positive for HHV-8 at the
first time point but only weakly positive at the second (table
1). PCR signals were not detected at time points 3 and 4 but
were at the next several time points (table 1). The negative and
positive samples were detected by Southern blot hvbridization,
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A

B
Figure 1. A, Solution-based polymerase chain reaction (PCR) of
pelleted viral DNA. 5 mL of patient A's serum was pelleted (see
text). DNA extracted from pelleted material (30 ng) was PCR-amplifled, using 330 Bam fragment primer. A, Ethidium bromide- stained
gel: lane I , 330 Bam fragment, amplified from pelleted viral DNA;
lane 2, negative control; lane 3, positive control. B, Southern blot
analysis of gel, using labeled 330 Bam fragment as probe.

using the labeled 233 -bp frag me nt as a probe. The detecti on
of HHV -8 also correlated wit h relapse an d progression of patient A ' s tum or. Of note , the negative samples were drawn
during foscarnet treatment. PBMC from pati ent B we re posi tive
for HH V-8 sequences in itiall y bu t su bsequently became negative (table I). During this per iod, no trea tme nt was given, and
there was no change in his clini cal status .
In order to study whether a cell-free phase of HH V-8 ex ists,
solution-based PCR was don e directly on plasma samples at
diffe rent time points. Initially, HH V-8 signals were not detectable in the plas ma . To increase sensitivity and minimize detec tion of contaminating cellular DNA, the viru s pa rticles w ere
pe lleted by high -spe ed centri fugation and treated with DNa se
before DN A extraction and PCR analys is . Strong pos itive sig nals were detected in the DNA extracted (30 ng) from the
pe lleted virus treated with DN ase, as demonstrated by ethidium-brornide gels and by Southern blot analysis of the same
gels, using a rad iolabe led 330 Bam probe (figure lA, E , res pec tively) . As shown in table 1, HHV -8 sig nals were detecte d in
both tre ated and untreated samp les from patient A (tim e p oints
1, 5, and 7) and patie nt B (time poi nt 1). PCR resu lts were
negative at other time points (patient A: time points 3 and 4;
patie nt B : time point 2 and later), when PBMC were also
negative .
Detection and localization ofHHV-8 ill PBMC subsets. To
determine the cell type harboring HHV -8, in situ hybridization
and IS-PCR we re done. HH V-8 signa ls were found , by ISPCR , in 20 % - 30% of the PBM C from patient A and 11% 23% of tho se from patient E (figure 2A , B, respective ly). No
such sign als we re detected in norm al control PBMC fro m a
disease -free HIV- I - seronegative person (data not shown) .
There were relatively fewer HHV-8-positive PBMC detected
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by sta ndar d in situ hybridization in the 2 patients (0.8% -0.3% ;
data not sho wn). Signals were localized near the nuc lear membrane w ithin the cytoplasm. consistent with the ep isomal nature
of thi s virus , as previously described [7].
To determine which subpopulation of monon uclear cells ha rbor HH V-8. PBM C from patient A were first separated with
immunomagnetic bead s into T and B lymph ocyte fraction s,
and PCR was done on extracted DNA from cac h frac tion (table
1). HHV -8 signa ls were repeat ed ly detected (patient A: time
po ints 6 and 7) in th e B cell fraction; the corresp onding T
ce ll fraction was wea kly positi ve (data not shown). This resu lt
supports recent findings of Ambroziac et al. [6] that I-1J-l V-8
signa ls are detected main ly in the B cell fraction. However,
when T and B lymphocyte fractions were analyzed by highl y
sensi tive IS- PCR, in w hich a sing le copy of a gene or frag ment
of a gene can be amp lified in situ [12, 13], some T cells were
also positive , althoug h significantly less (range, 1.2% - 2.2% in
pa tient A and 0.1 % - 0.9% in patient B) than in the B ce ll
fraction (range, 39%-48 % in patient A and 27% - 33% in patient E) (figure 2C, D).

Di sc ussion
Until now , ev idence of H HV -8 sequences in peri pheral blood
ce lls from KS patients has been bas ed on PCR or DNA extracted from mononuclear cells. We detected HH V-8 signals
by an in situ PCR method in PBMe. Althoug h PCR anal ysi s
of pa nned lymphocyte popu lations detected signa ls in only the
B cell frac tion, we dem onstrated that HH V-8 has a broader
tropi sm and can infect T lym phocytes. 1t is possible that the
HHV -8-positive cells containe d in the T cell fraction were
contaminatin g B cells. However, by combining an immunohistoc hemi stry assay with in situ PCR [ 12, 13]. we confirmed that
sma ll percentage s of T cells were indeed infected with HH V8 in the PBMC of both our patients. Detection of this se que nce
in B cells is consis tent with a recent report of HHV-8- positi ve
B lymphoma cell lines deri ved from body-cavity - associated
lym phomas in AIDS patients [7]. Und er circumstances of severe immunosuppression, infection by I-I1-:rV-8 ma y directly or
indirectly contribute to tra nsformation of B cells. The dire ct
role of HHV-8 in the development of bod y-cavity lymphom as
is complicated by the coinfection of th ese cells by EBV. Detection of HHV- 8 in plasma from DN ase-treated and untreated
samples suggests that the signa l mu st origin ate from intact
virus part icles rath er than from con tam inating infected cellu lar
DNA and that HH V-8 has virem ic stages in which cell-free
particle s are found in the circulation. Negative PCR resu lts
from both fractions (plasma and PB MC) at other tim e points
ind icate that HHV-8 may also go through periods of latency,
when it is extremely diffic ult to detect by PCR.
The host ra ng e for HHV-8 has not been clearl y defin ed.
A recent stud y has dem onst rat ed that th e spi nd le and MVE C
of the KS le sion s are po sit ive fo r HH V -8 se que nces by IS peR [8]. W e have also fo und infection of M VEC, spi ndle
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Figure 2. In situ po lymeras e chain reaction (PC R) of periphe ral blo od mononuclear ce lls (PB MC) fro m patient s A (A) and B (B) . Stu dy
used HH V-8 pr im er pa ir for in situ PCR, and sub se quently , bio tinylated HH V-8 pro be from 330 Bam seq uence . A rrows in A and B indicate
cells with positi ve signa l. C, D, In situ PCR pe rfo rm ed on T and B lymphocyte subpopulations fro m both pat ients. Result s are shown for T
and B lymphoc yte subpopulations isolated by ce ll so rt ing fro m patient A. Us ing HHV -8 primer pair for in si tu p eR and then hyb ridizing w ith
HH V-8- spe cifi c bio tiny lated probe, evidenc e of HH V-8 sequenc es is visible (arrow s) in both T (C) and B (D) lymph ocyte subs ets . % HH V8 - infected cells in B lym phocyte fract ions were significa ntly higher (se e text).

cell s, and various layers of dermis in the tissues of all thre e
major types of KS (i.e., classic al, Afri can endemi c, and
AIDS-asso ciated; unpubli shed data). The data in this report
support the contention that HH V -8 is a unique viral agent
able to infect PBMC with an intermittent viremic phase.
There may be a primary infecti on of mononuclear cells, followed by infection of MVEC or transient viremia and active
replication of the virus from latent site(s) during immunosuppression. Our findings that infection of PBM C by HEV8 may be cyclical could also explain why this agent cannot
consistentl y be detected within PBMC in all KS patients [5].
It will be important to study a larger longitudinal panel of
patients to determine the relationship between HHV -8 viremia, clini cal status, and progression to the development of
Kaposi ' s sarcoma.

Referenc es
1. Dupin N, Grandadam M, Calvez V, et a1. Herpesvirus-like DNA sequences
in patients with Mediterranean Kaposi' s sarcoma. Lancet 1995;345:
761-2.
2. Chang Y, Cesarrnan E, Pessin MS, et al. Identification of herpesvirus-like
DNA sequences in AIDS associated Kaposi's sarcoma. Science 1994;
266:1865- 9.
3. Karcher DS, Alkan S. Herpes-like DNA sequences, AIDS-related tumors,
and Castleman' s disease. N Eng! J Med 1995; 333:797- 8.
4. Rady PL, Yen A, Rollefson JL, et a1. Herpesvirus-like DNA sequences in
non-Kaposi'ssarcoma skin lesions of transplant patients. Lancet 1995;
345:1339-40.
5. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's
sarcoma in peripheral blood of HIV-infected individuals and progression
to Kaposi' s sarcoma. Lancet 1995;346:799- 802.
6. Ambroziak lA, Blackboum DJ, Hemdier BG, et al. Herpes-like sequences
in HIV-infected and uninfected Kaposi' s sarcoma patients. Science
1995;268:582- 3.

JID 1996; 174 (November)

Concise Communications

7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-vassociated herpesvirus-like DNA sequences in AIDS-related
body-cavity-based lymphomas. N Engl J Med 1995;332:1186~91.
8. Boshoff C, Schulz TF, Kennedy MM, et a!. Kaposi's sarcoma-iassociated
herpesvirus infects endothelial and spindle cells. Nature Med 1995;12:
1274~8.

9. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis
1994;26:749-52.
10. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in
Kaposi's sarcoma in patients with and those without HIV infection. N
Engl J Med 1995;332:1181-5.

1105

II. Willey RL, Martin MA. Increase in soluble CD4 binding to and CD4
induced dissociation of gpl20 from virions correlates with infectivity of human immunodeficiency virus type 1. J Virol 1994; 68:
1029-39.
12. Bagasra 0, Seshamma T, Hansen J, Pomerantz R. In situ polymerase chain
reaction and hybridization to detect low abundance nucleic acid targets.
In: Current protocols in molecular biology. Ausubel FM, Brent R,
Kingston RE, et a!., eds. New York, NY: John Willey & Sons, 1995:
Sec 14.8.1.
13. Bagasra 0, Hauptman HP, Lischner HW, Sachs M, Pomerantz RJ. Detection of human immunodeficiency virus type I provirus in mononuclear
cells by in situ polymerase chain reaction. N Engl J Med 1992;326:
1385~91.

